AES
54
7
AMGN
38
4
CME
52
7
CF
41
-7
MTCH
70
11
AME
75
3
MCHP
58
11
MU
79
4
CVS
40
3
YUM
58
2
DLTR
58
-5
PAYX
41
5
FLS
63
2
EOG
37
4
AVB
39
5
PFG
55
2
OMC
66
-3
LRCX
64
2
KMI
63
10
MOS
32
3
AES
54
7
AMGN
38
4
CME
52
7
CF
41
-7
MTCH
70
11
AME
75
3
MCHP
58
11
MU
79
4
CVS
40
3
YUM
58
2
DLTR
58
-5
PAYX
41
5
FLS
63
2
EOG
37
4
AVB
39
5
PFG
55
2
OMC
66
-3
LRCX
64
2
KMI
63
10
MOS
32
3
Financhill
Back

PIMCO Preferred and Capital Securities Active ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
58

PRFD
PIMCO Preferred and Capital Securities Active ETF

Last Price:
$51.71
Seasonality Move:
3.58%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.94
Seasonality Move:
25.93%
Buy
58
PIMCO Preferred and Capital Securities Active ETF (PRFD) is a Buy

Is PIMCO Preferred and Capital Securities Active ETF a Buy, Sell or Hold?

  • The current PIMCO Preferred and Capital Securities Active ETF [PRFD] share price is $51.64. The Score for PRFD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • PRFD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRFD Stock Price Chart

What is PIMCO Preferred and Capital Securities Active ETF's stock price today?

  • The PIMCO Preferred and Capital Securities Active ETF share price today is $51.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRFD is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

PRFD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.49 Buy
Relative Strength Index (14 RSI): 49.21 Sell
Chaikin Money Flow: -18967 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.53 - 51.73) Buy
Bollinger Bands (100): (51.2 - 51.9) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

PRFD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.64 Buy
20-day SMA: 51.66 Sell
50-day SMA: 51.74 Sell
200-day SMA: 50.88 Buy
8-day EMA: 32.75 Buy
20-day EMA: 17.04 Buy
50-day EMA: 7.64 Buy
200-day EMA: 2.03 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

PIMCO Preferred and Capital Securities Active ETF Earnings Growth & PRFD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

PIMCO Preferred and Capital Securities Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):